BR

Bhaskara Rao Peddi

Active Director Director DIN 09120578
DIN 09120578 First appointment Mar 2021 Primary industry Pharma
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 2 active board seats
Total affiliations 2 Since Mar 2021
Shareholding value β€’β€’β€’β€’ Premium profile

About Bhaskara Rao Peddi

Data last updated:

Bhaskara Rao Peddi is a Director at Ryptus Pharmaceuticals Private Limited (since 2022) and Designated Partner at Ryptus Life Sciences Llp (since 2021). The companies operate in Pharma and Chemicals and Materials.

DIN 09120578
Primary Designation Director
Industry Pharma
First Appointment 23 Mar 2021
Oldest Company Age 5 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Director31 Aug 20222022Active
Designated Partner23 Mar 20212021Active

Board colleagues of Bhaskara Rao Peddi

Directorship timeline

Open interactive timeline →
Ryptus Life Sciences Llp
Ryptus Pharmaceuticals Private Limited
Premium access

Shareholding and investment profile for Bhaskara Rao Peddi

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Bhaskara Rao Peddi

Bhaskara Rao Peddi currently holds 2 directorships: Ryptus Pharmaceuticals Private Limited (Director, since 31 Aug 2022); Ryptus Life Sciences Llp (Designated Partner, since 23 Mar 2021).

Bhaskara Rao Peddi was first appointed on 23 Mar 2021 as Designated Partner at Ryptus Life Sciences Llp. The most recent appointment on record is 31 Aug 2022 at Ryptus Pharmaceuticals Private Limited.

The current boards of Bhaskara Rao Peddi's companies include Mohammed Naveed Yosuf (Ryptus Pharmaceuticals Private Limited), Raghuveer Peddi (Ryptus Pharmaceuticals Private Limited).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available